Impact of prophylactic TNF blockade in the dual PD-1 and CTLA-4 immunotherapy efficacy and toxicity.

Alvarez, Maite; Otano, Itziar; Minute, Luna; Ochoa, Maria Carmen; Perez-Ruiz, Elisabeth; Melero, Ignacio; Berraondo, Pedro

Alvarez, Maite; Otano, Itziar; Minute, Luna; Ochoa, Maria Carmen; Perez-Ruiz, Elisabeth; Melero, Ignacio; Berraondo, Pedro.

Afiliación

Alvarez M; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain.
Otano I; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
Minute L; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain.
Ochoa MC; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
Perez-Ruiz E; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain.
Melero I; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
Berraondo P; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain.

Cell Stress ; 3(7): 236-239, 2019 Jun 27.

Article en En | MEDLINE | ID: mdl-31309173

Palabras clave

CTLA-4; PD-1; cancer; colitis; immunotherapy; toxicity; tumor necrosis factor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Stress Año: 2019 Tipo del documento: Article País de afiliación: España

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google